Vessel Fractional Flow Reserve and Graft Vasculopathy in Heart Transplant Recipients.
Allografts
/ blood supply
Computer-Aided Design
Coronary Angiography
/ methods
Coronary Artery Disease
/ diagnosis
Coronary Vessels
/ diagnostic imaging
Female
Fractional Flow Reserve, Myocardial
Heart Transplantation
/ adverse effects
Humans
Male
Middle Aged
Postoperative Complications
/ diagnosis
Reproducibility of Results
Risk Assessment
/ methods
Journal
Journal of interventional cardiology
ISSN: 1540-8183
Titre abrégé: J Interv Cardiol
Pays: United States
ID NLM: 8907826
Informations de publication
Date de publication:
2020
2020
Historique:
received:
17
02
2020
accepted:
12
05
2020
entrez:
1
8
2020
pubmed:
1
8
2020
medline:
1
12
2020
Statut:
epublish
Résumé
Cardiac allograft vasculopathy (CAV) remains the Achilles' heel of long-term survival after heart transplantation (HTx). The severity and extent of CAV is graded with conventional coronary angiography (COR) which has several limitations. Recently, vessel fractional flow reserve (vFFR) derived from COR has emerged as a diagnostic computational tool to quantify the functional severity of coronary artery disease. The present study assessed the usefulness of vFFR to detect CAV in HTx recipients. In HTx patients referred for annual check-up, undergoing surveillance COR, the extent of CAV was graded according to the criteria proposed by the international society of heart and lung transplantation (ISHLT). In addition, three-dimensional coronary geometries were constructed from COR to calculate pressure losses using vFFR. In 65 HTx patients with a mean age of 53.7 ± 10.1 years, 8.5 years (IQR 1.90, 15.2) years after HTx, a total number of 173 vessels (59 LAD, 61 LCX, and 53 RCA) were analyzed. The mean vFFR was 0.84 ± 0.15 and median was 0.88 (IQR 0.79, 0.94). A vFFR ≤ 0.80 was present in 24 patients (48 vessels). HTx patients with a history of ischemic cardiomyopathy (ICMP) had numerically lower vFFR as compared to those with non-ICMP (0.70 ± 0.22 vs. 0.79 ± 0.13, The impairment in epicardial conductance assessed by vFFR in a subgroup of patients without CAV according to standard ISHLT criteria suggests the presence of a diffuse vasculopathy undetectable by conventional angiography. Therefore, we speculate that vFFR may be useful in risk stratification after HTx.
Sections du résumé
BACKGROUND
BACKGROUND
Cardiac allograft vasculopathy (CAV) remains the Achilles' heel of long-term survival after heart transplantation (HTx). The severity and extent of CAV is graded with conventional coronary angiography (COR) which has several limitations. Recently, vessel fractional flow reserve (vFFR) derived from COR has emerged as a diagnostic computational tool to quantify the functional severity of coronary artery disease.
PURPOSE
OBJECTIVE
The present study assessed the usefulness of vFFR to detect CAV in HTx recipients.
METHODS
METHODS
In HTx patients referred for annual check-up, undergoing surveillance COR, the extent of CAV was graded according to the criteria proposed by the international society of heart and lung transplantation (ISHLT). In addition, three-dimensional coronary geometries were constructed from COR to calculate pressure losses using vFFR.
RESULTS
RESULTS
In 65 HTx patients with a mean age of 53.7 ± 10.1 years, 8.5 years (IQR 1.90, 15.2) years after HTx, a total number of 173 vessels (59 LAD, 61 LCX, and 53 RCA) were analyzed. The mean vFFR was 0.84 ± 0.15 and median was 0.88 (IQR 0.79, 0.94). A vFFR ≤ 0.80 was present in 24 patients (48 vessels). HTx patients with a history of ischemic cardiomyopathy (ICMP) had numerically lower vFFR as compared to those with non-ICMP (0.70 ± 0.22 vs. 0.79 ± 0.13,
CONCLUSION
CONCLUSIONS
The impairment in epicardial conductance assessed by vFFR in a subgroup of patients without CAV according to standard ISHLT criteria suggests the presence of a diffuse vasculopathy undetectable by conventional angiography. Therefore, we speculate that vFFR may be useful in risk stratification after HTx.
Identifiants
pubmed: 32733172
doi: 10.1155/2020/9835151
pmc: PMC7376430
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
9835151Informations de copyright
Copyright © 2020 Sakura Nagumo et al.
Déclaration de conflit d'intérêts
The authors declare that there are no conflicts of interest regarding the publication of this paper.
Références
J Heart Lung Transplant. 2010 Jul;29(7):717-27
pubmed: 20620917
J Am Coll Cardiol. 2017 May 2;69(17):2212-2241
pubmed: 28291663
Eur Heart J. 2018 Sep 14;39(35):3314-3321
pubmed: 30137305
Transpl Int. 2010 Nov;23(11):1094-104
pubmed: 20477994
J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264
pubmed: 30153967
EuroIntervention. 2017 Aug 25;13(6):634-643
pubmed: 28844026
Am J Cardiol. 2007 Jun 1;99(11):1603-7
pubmed: 17531589
JACC Heart Fail. 2017 Dec;5(12):891-901
pubmed: 29191295
Eur Heart J. 2014 Oct 1;35(37):2541-619
pubmed: 25173339
Circulation. 2016 May 17;133(20):1945-50
pubmed: 27143679
EuroIntervention. 2019 May 14;:
pubmed: 31085504
Transplantation. 1996 Jan 15;61(1):46-53
pubmed: 8560573
Circulation. 2003 Sep 30;108(13):1605-10
pubmed: 12963639
J Am Coll Cardiol. 2016 Jul 5;68(1):80-91
pubmed: 27364054
Circulation. 1992 Mar;85(3):979-87
pubmed: 1537134
J Am Coll Cardiol. 1986 Jan;7(1):103-13
pubmed: 3941196
Catheter Cardiovasc Interv. 2018 Dec 1;92(7):E527-E536
pubmed: 30265435
Chest. 2000 Dec;118(6):1792-800
pubmed: 11115475
Circulation. 2001 Aug 7;104(6):653-7
pubmed: 11489770
J Cardiovasc Transl Res. 2013 Apr;6(2):263-77
pubmed: 23135991
J Heart Lung Transplant. 2006 Jul;25(7):765-71
pubmed: 16818118
N Engl J Med. 2009 Jan 15;360(3):213-24
pubmed: 19144937